IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

FDA accepts Sanofi's new diabetes drug application

11:39 PM MDT | July 7, 2014 | Natasha Alperowicz

Sanofi (Paris) said today that the US FDA has accepted for review the company’s new drug application for Toujeo, an investigational basal insulin. This follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicine Agency for EU countries on 27 May 2014. “By reaching this key milestone in the approval process, we are pleased to take another step forward with Toujeo, an investigational new based insulin that has been evaluated in a broad range of people living with diabetes,” said Pierre Chancel, senior...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa